Proteome Sciences plc (LON:PRM – Get Free Report) fell 2.7% on Monday . The company traded as low as GBX 3.60 ($0.05) and last traded at GBX 3.60 ($0.05). 1,183,886 shares traded hands during trading, an increase of 573% from the average session volume of 175,815 shares. The stock had previously closed at GBX 3.70 ($0.05).
Proteome Sciences Stock Up 1.8 %
The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The firm’s fifty day moving average price is GBX 4.10 and its 200-day moving average price is GBX 3.43. The company has a market cap of £11.51 million, a price-to-earnings ratio of -2.82 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- PayPal Stock: Too Cheap to Ignore, Too Strong to Miss
- Roth IRA Calculator: Calculate Your Potential Returns
- Progress Software: Making Progress Driven by the AI Revolution
- Retail Stocks Investing, Explained
- Intel-Taiwan Semiconductor Alliance Fuels Turnaround Hopes
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
